AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163U906. A total of 3 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $785,000 | +39.4% | 83,500 | +13.5% | 0.00% | -33.3% |
Q2 2020 | $563,000 | +47.0% | 73,600 | +18.9% | 0.00% | 0.0% |
Q1 2020 | $383,000 | +15.0% | 61,900 | +125.9% | 0.00% | +50.0% |
Q4 2019 | $333,000 | +38.8% | 27,400 | +31.7% | 0.00% | 0.0% |
Q3 2019 | $240,000 | -96.6% | 20,800 | -97.0% | 0.00% | -96.9% |
Q2 2019 | $7,033,000 | +18908.1% | 704,000 | +24175.9% | 0.06% | – |
Q1 2019 | $37,000 | -39.3% | 2,900 | -27.5% | 0.00% | -100.0% |
Q4 2018 | $61,000 | +1120.0% | 4,000 | -50.0% | 0.00% | – |
Q3 2018 | $5,000 | -98.5% | 8,000 | -53.8% | 0.00% | -100.0% |
Q2 2018 | $337,000 | +15.4% | 17,300 | +19.3% | 0.00% | 0.0% |
Q1 2018 | $292,000 | +52.1% | 14,500 | 0.0% | 0.00% | +200.0% |
Q4 2017 | $192,000 | -43.7% | 14,500 | -21.6% | 0.00% | -66.7% |
Q3 2017 | $341,000 | +22.7% | 18,500 | +22.5% | 0.00% | 0.0% |
Q2 2017 | $278,000 | +5460.0% | 15,100 | +7450.0% | 0.00% | – |
Q1 2017 | $5,000 | -70.6% | 200 | -71.4% | 0.00% | – |
Q2 2016 | $17,000 | -70.2% | 700 | -63.2% | 0.00% | -100.0% |
Q4 2015 | $57,000 | -55.1% | 1,900 | -40.6% | 0.00% | -50.0% |
Q3 2015 | $127,000 | -90.7% | 3,200 | -83.8% | 0.00% | -89.5% |
Q2 2015 | $1,360,000 | +452.8% | 19,700 | +337.8% | 0.02% | +375.0% |
Q1 2015 | $246,000 | +1.2% | 4,500 | -21.1% | 0.00% | 0.0% |
Q4 2014 | $243,000 | +539.5% | 5,700 | +375.0% | 0.00% | +300.0% |
Q3 2014 | $38,000 | +81.0% | 1,200 | +20.0% | 0.00% | – |
Q2 2014 | $21,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 61,900 | $383,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
SIMPLEX TRADING, LLC | 172 | $106,000 | 0.00% |